Log In
Copyright © 2006 American Chemical Society
April 3, 2006 Cover
Volume 84, Issue 14
COVER: Burle Electro-OpticsChanneltron electron multiplier.
Volume 84, Issue 14
PITTCON
Attendance may be slipping, but enthusiasm for new and innovative analytical instrumentation has not waned
COVER: Burle Electro-OpticsChanneltron electron multiplier.
Credit: Photo by Mitch Jacoby
» Full Article
April 3, 2006 Issue
Volume 84, Issue 14
April 3, 2006 Issue, Vol. 84 | Iss. 14
Attendance may be slipping, but enthusiasm for new and innovative analytical instrumentation has not waned
(pp. 45-51)
Features
Government & Policy
Agency begins phasing out paper grant application submissions in favor of electronic process (pp. 29-30)
Cover Story: Better Than Ever At Pittcon 2006
Analyzing Vaccines
Complicated mixtures that make up therapeutics vaccines provide diverse analytical challenges
(pp. 52-54)Bioimaging With Mass Spectrometry
High-resolution maps of molecular species distributions are poised to benefit biology, medicine
(pp. 55-56)Private Eye In The Lab
New tools and analytical methods aid chemists in forensic investigations
(p.57)Multitasking Cells
Experiments in microfluidic devices suggest surprising roles for red blood cells
(p.58)Building Bridges
Coalition advocates for nontraditional grant review mechanism to foster deep innovation
(p.60)Chinese Instrument Market Warms Up
Chinese instrument industry lags behind the world's but has tremendous room for growth
(p.61)News of the Week
Chemists Converge In Atlanta
Nearly 13,000 chemical scientists network, share research, enjoy March Madness
(p.11)A Chain Of Six Indium Atoms
Group 13 element shows surprising ability to form a linear oligomer
(p.12)RNAi Works In Monkeys
Liposome system delivers short RNAs, gene silencing, and sustained cholesterol reduction
(p.12)Schering Escapes Merck's Grasp
German giant Bayer steps in as white knight, topping earlier hostile bid
(p.13)Noninvasive Glucose Detection
Gold nanoparticle method detects glucose at the low levels found in healthy people
(p.15)Wacker IPO
Family-owned firm hopes to raise at least $300 million with stock offering on Frankfurt exchange
(p.15)European Generics
Sanofi-Aventis and Ranbaxy are the latest to bid for Central European pharma firms
(p.16)Solving Structures Without Crystals
Method provides structural solutions to materials lacking long-range order
(p.16)Departments
Business
Several small pharmaceutical chemical makers credit the region for their success
(pp. 23-24)
Chinese instrument industry lags behind the world's but has tremendous room for growth
(p.61)Concentrates
(pp. 19-20)
(pp. 19-20)- Novartis fills its drug pipeline
- Antigenics' cancer vaccine disappoints
- Biocon wins Nobex auction
- Ashland to buy Degussa water treatment unit
- Dynavax buys Rhein Biotech
- Ciba launches freshness indicator
- Chemtura buys seed business
- Invista sells German fibers
- Kemira, UEE in cetane pact
- Merck snaps up agbiotech firm
- Cognis buys polymers maker
- Holland isless sweet
- Enterprise sets propylene plant
- Petrobras moves on big complex
- Prices rise in February
- Business Roundup
Government & Policy
Agency begins phasing out paper grant application submissions in favor of electronic process
(pp. 29-30)
Science & Technology
Brewing beer from cereals relies on a variety of biological, chemical, and physical processes
(p.39)
Bioluminescence provides practical applications while still remaining a mystery
(pp. 36-38)
Complicated mixtures that make up therapeutics vaccines provide diverse analytical challenges
(pp. 52-54)
High-resolution maps of molecular species distributions are poised to benefit biology, medicine
(pp. 55-56)
New tools and analytical methods aid chemists in forensic investigations
(p.57)
Experiments in microfluidic devices suggest surprising roles for red blood cells
(p.58)
Coalition advocates for nontraditional grant review mechanism to foster deep innovation
(p.60)
Attendance may be slipping, but enthusiasm for new and innovative analytical instrumentation has not waned
(pp. 45-51)Career & Employment
Growth of commercial enzyme-mediated processes points to the future of the chemical industry
(pp. 69-71)
Growth of commercial enzyme-mediated processes points to the future of the chemical industry
(pp. 69-71)